Helsinki Institute of Life Science
FIMM High Throughput Biomedicine unit and the Faculty of Pharmacy form together the HiLIFE Drug Discovery, Chemical Biology and Screening platform.The expertise within the platform units includes drug discovery & chemical biology process guidance and advice, assay development, high throughput and high content screening, chemoinformatics, follow-up assays, in vitro ADMET and connections to organic/medicinal chemistry.